Research News

COVID-19 Vaccine less efficient in Immunocompromised patients

This review, led by Dr Raghav Sundar and Dr Soon Yu Yang, show that covid-19 vaccines provide significantly lower protection in immunocompromised patients. It highlights the importance of a second dose of covid-19 vaccine and recommends administration of a third covid-19 vaccines dose to confer improved protection for immunocompromised patients.

 

Read more: https://doi.org/10.1136/bmj-2021-068632

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. …

Read More →
Research News

PHF2 regulates genome topology and DNA replication in neural stem cells via cohesion

When a cell divides to make new cells, it needs to copy its DNA so that each new cell has …

Read More →
Research News

METTL8 links mt-tRNA m3C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity

Glioblastoma is the most common and lethal form of adult brain cancer. The presence of cancer stem cells (so-called glioma …

Read More →